These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2663796)

  • 1. Enhancement of murine bone marrow ablation by combining whole body hyperthermia with total body irradiation and cyclophosphamide.
    Mivechi NF; Ogilvie PD
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):117-23. PubMed ID: 2663796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of whole-body hyperthermia and cyclophosphamide on natural killer cell activity in murine erythroleukemia.
    Shen RN; Hornback NB; Shidnia H; Lu L; Broxmeyer HE; Brahmi Z
    Cancer Res; 1988 Aug; 48(16):4561-3. PubMed ID: 3165052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of irradiation on thermal sensitivity of bone marrow progenitors.
    Mivechi NF; Li GC
    Int J Hyperthermia; 1988; 4(5):537-46. PubMed ID: 3292668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.
    Hartsell WF; Czyzewski EA; Ghalie R; Kaizer H
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):69-73. PubMed ID: 7536723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1).
    Loewenthal E; Weiss L; Samuel S; Or R; Slavin S
    Bone Marrow Transplant; 1993 Aug; 12(2):109-13. PubMed ID: 8401354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide 24 hours before or after total body irradiation: effects on lung and bone marrow.
    Yan R; Peters LJ; Travis EL
    Radiother Oncol; 1991 Jul; 21(3):149-56. PubMed ID: 1924849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body hyperthermia combined with hyperfractionated irradiation of the thorax in dog: acute physiological response.
    McChesney Gillette S; Dawson CA; Scott RJ; Rickaby DA; Powers BE; Johnston MR; Chen C; Gillette EL
    Int J Hyperthermia; 1993; 9(3):369-82. PubMed ID: 8515140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of whole-body hyperthermia and irradiation in the treatment of AKR mouse leukemia.
    Steeves RA; Robins HI; Miller K; Martin P; Shecterle L; Dennis W
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Dec; 52(6):935-47. PubMed ID: 3319924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late effects of cyclophosphamide and total body irradiation as a conditioning regimen for bone marrow transplantation in rats (a preliminary report).
    Zurcher C; Varekamp AE; Solleveld HA; Durham SK; De Vries AJ; Hagenbeek A
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jun; 51(6):1059-68. PubMed ID: 3298105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
    Robins HI; Longo WL; Steeves RA; Cohen JD; Schmitt CL; Neville AJ; O'Keefe S; Lagoni R; Riggs C
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):909-20. PubMed ID: 2182581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia.
    Dusenbery KE; Daniels KA; McClure JS; McGlave PB; Ramsay NK; Blazar BR; Neglia JP; Kersey JH; Woods WG
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):119-28. PubMed ID: 7995742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sequence and time interval between cyclophosphamide and total body irradiation on lung and bone marrow damage following bone marrow transplantation in mice.
    Nielsen OS; Safwat A; Overgaard J
    Radiother Oncol; 1993 Oct; 29(1):51-9. PubMed ID: 8295988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of glutathione redox status in lung and liver by conditioning regimens and keratinocyte growth factor in murine allogeneic bone marrow transplantation.
    Ziegler TR; Panoskaltsus-Mortari A; Gu LH; Jonas CR; Farrell CL; Lacey DL; Jones DP; Blazar BR
    Transplantation; 2001 Oct; 72(8):1354-62. PubMed ID: 11685103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
    Anderson JE; Appelbaum FR; Schoch G; Gooley T; Anasetti C; Bensinger WI; Bryant E; Buckner CD; Chauncey T; Clift RA
    J Clin Oncol; 1996 Jan; 14(1):220-6. PubMed ID: 8558201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
    Petersen FB; Buckner CD; Appelbaum FR; Sanders JE; Bensinger WI; Storb R; Deeg HJ; Witherspoon RP; Sullivan KM; Clift RA
    Bone Marrow Transplant; 1992 Jul; 10(1):83-8. PubMed ID: 1515884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
    Demirer T; Petersen FB; Appelbaum FR; Barnett TA; Sanders J; Deeg HJ; Storb R; Doney K; Bensinger WI; Shannon-Dorcy K
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1103-9. PubMed ID: 7607931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.
    Helenglass G; Powles RL; McElwain TJ; Lakhani A; Milan S; Gore M; Nandi A; Zuiable A; Perren T; Forgeson G
    Bone Marrow Transplant; 1988 Jan; 3(1):21-9. PubMed ID: 3048467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of radiation dose rate and cyclophosphamide on pulmonary toxicity after total body irradiation in a mouse model.
    Safwat A; Nielsen OS; El-Badawy S; Overgaard J
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):85-91. PubMed ID: 12118569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.